Concepedia

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

Satu Mustjoki, Marja Ekblom, T. Petteri Arstila, Ingunn Dybedal, Pearlie K. Epling‐Burnette, François Guilhot, Henrik Hjorth‐Hansen, Martin Höglund, Panu E. Kovanen, Tuisku Laurinolli,

Leukemia · 2009 · 320 citations · 16 references

DOI

Concepts

References

16

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text

, , +13

Discovery of <i>N</i>-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays

Louis J. Lombardo, Francis Y. Lee, Ping Chen et al. · Journal of Medicinal Chemistry · 2004 · 1.3K citations · Full text

, , +13

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

Marcus Bantscheff, Dirk Eberhard, Yann Abraham et al. · Nature Biotechnology · 2007 · 1K citations

, , +14

Characteristics of human large granular lymphocytes and relationship to natural killer and K cells

Tuomo Timonen, Ortaldo JR, R B Herberman · The Journal of Experimental Medicine · 1981 · 993 citations · Full text

, , +12

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

Uwe Rix, Oliver Hantschel, Gerhard Dürnberger et al. · Blood · 2007 · 663 citations · Full text

, , +17